ArticleFrontiers in cardiovascular medicine2025
Relationship between estimated pulse wave velocity and the risk of future sarcopenia in middle-aged and older Chinese adults: evidence from the China Health and Retirement Longitudinal Study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Sarcopenia, common among older adults, is associated with adverse health outcomes. This study explores the relationship between estimated pulse wave velocity (ePWV), a marker of arterial stiffness, and sarcopenia to support the early diagnosis and prevention strategies. Methods: Using data from two waves (2011 and 2015) of the China Health and Retirement Longitudinal Study (CHARLS), we conducted a nationally representative cohort study. ePWV was calculated at baseline, and sarcopenia was identified based on the Asian Working Group for Sarcopenia (AWGS) 2019 criteria. We used multivariate logistic regression and restricted cubic spline (RCS) analyses to investigate the ePWV-sarcopenia relationship. Results: Among 6,639 participants followed for 4 years, 11.1% were diagnosed with sarcopenia. Initial analyses indicated a positive correlation between ePWV and sarcopenia ( Conclusions: In middle-aged and elderly Chinese adults, ePWV variations may be linked to sarcopenia risk, potentially serving as a predictive marker. The non-linear relationship indicates complex underlying mechanisms, meriting further research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.